KR20050108376A - 시아노-이소벤조퓨란의 제조방법 - Google Patents
시아노-이소벤조퓨란의 제조방법 Download PDFInfo
- Publication number
- KR20050108376A KR20050108376A KR1020057016274A KR20057016274A KR20050108376A KR 20050108376 A KR20050108376 A KR 20050108376A KR 1020057016274 A KR1020057016274 A KR 1020057016274A KR 20057016274 A KR20057016274 A KR 20057016274A KR 20050108376 A KR20050108376 A KR 20050108376A
- Authority
- KR
- South Korea
- Prior art keywords
- fluorophenyl
- dihydro
- isobenzofurancarbonitrile
- hydroxymethyl
- bis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims description 16
- DNEVVXBMQZYGEI-UHFFFAOYSA-N 2-benzofuran-1-carbonitrile Chemical compound C1=CC=CC2=C(C#N)OC=C21 DNEVVXBMQZYGEI-UHFFFAOYSA-N 0.000 title description 3
- YXCRMKYHFFMNPT-UHFFFAOYSA-N 1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound C1=CC(F)=CC=C1C1C2=CC=C(C#N)C=C2CO1 YXCRMKYHFFMNPT-UHFFFAOYSA-N 0.000 claims abstract description 47
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims abstract description 31
- XEEGWTLAFIZLSF-UHFFFAOYSA-N 1-oxo-3h-2-benzofuran-5-carbonitrile Chemical compound N#CC1=CC=C2C(=O)OCC2=C1 XEEGWTLAFIZLSF-UHFFFAOYSA-N 0.000 claims abstract description 30
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 claims abstract description 28
- 229960001653 citalopram Drugs 0.000 claims abstract description 28
- -1 4-fluorophenyl magnesium halide Chemical class 0.000 claims abstract description 22
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 11
- GDOCLIOVHKLEOU-UHFFFAOYSA-N 4-(4-fluorobenzoyl)-3-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC(C#N)=CC=C1C(=O)C1=CC=C(F)C=C1 GDOCLIOVHKLEOU-UHFFFAOYSA-N 0.000 claims abstract description 10
- JOWBVIAXILQDHG-UHFFFAOYSA-N 4-[(4-fluorophenyl)-hydroxymethyl]-3-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC(C#N)=CC=C1C(O)C1=CC=C(F)C=C1 JOWBVIAXILQDHG-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 7
- 150000001298 alcohols Chemical class 0.000 claims abstract description 6
- 150000002576 ketones Chemical class 0.000 claims abstract description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 84
- 239000000203 mixture Substances 0.000 claims description 43
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- WDWABVHVASZWHB-UHFFFAOYSA-N 1,1-bis(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile Chemical compound C1=CC(F)=CC=C1C1(C=2C=CC(F)=CC=2)C2=CC=C(C#N)C=C2CO1 WDWABVHVASZWHB-UHFFFAOYSA-N 0.000 claims description 21
- 239000002904 solvent Substances 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 12
- BNUIKEORRSAIAY-UHFFFAOYSA-N 4-[bis(4-fluorophenyl)-hydroxymethyl]-3-(hydroxymethyl)benzonitrile Chemical compound OCC1=CC(C#N)=CC=C1C(O)(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 BNUIKEORRSAIAY-UHFFFAOYSA-N 0.000 claims description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 7
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 5
- 239000012458 free base Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 239000012312 sodium hydride Substances 0.000 claims description 5
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 5
- YXDXXGXWFJCXEB-UHFFFAOYSA-N 2-furonitrile Chemical compound N#CC1=CC=CO1 YXDXXGXWFJCXEB-UHFFFAOYSA-N 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- MLGVWRLCURBYNQ-UHFFFAOYSA-N 2-benzofuran-5-carbonitrile Chemical compound C1=C(C#N)C=CC2=COC=C21 MLGVWRLCURBYNQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000005605 benzo group Chemical group 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 150000002825 nitriles Chemical class 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 235000019687 Lamb Nutrition 0.000 claims 1
- 230000002051 biphasic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 2
- ZLXJXAMSNFFEFG-UHFFFAOYSA-N 1,3-dihydro-2-benzofuran-5-carbonitrile Chemical compound N#CC1=CC=C2COCC2=C1 ZLXJXAMSNFFEFG-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 45
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000012074 organic phase Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 23
- 239000008346 aqueous phase Substances 0.000 description 21
- 239000012071 phase Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- 239000007858 starting material Substances 0.000 description 13
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000725 suspension Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 description 8
- 239000006227 byproduct Substances 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 150000002009 diols Chemical class 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 5
- 125000004093 cyano group Chemical group *C#N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- WIHMBLDNRMIGDW-UHFFFAOYSA-N 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3h-2-benzofuran-5-carbonitrile;hydron;bromide Chemical compound [Br-].O1CC2=CC(C#N)=CC=C2C1(CCC[NH+](C)C)C1=CC=C(F)C=C1 WIHMBLDNRMIGDW-UHFFFAOYSA-N 0.000 description 3
- AITNMTXHTIIIBB-UHFFFAOYSA-N 1-bromo-4-fluorobenzene Chemical compound FC1=CC=C(Br)C=C1 AITNMTXHTIIIBB-UHFFFAOYSA-N 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 229960000584 citalopram hydrobromide Drugs 0.000 description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 2
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 2
- IUSPXLCLQIZFHL-UHFFFAOYSA-N 5-bromo-3h-2-benzofuran-1-one Chemical compound BrC1=CC=C2C(=O)OCC2=C1 IUSPXLCLQIZFHL-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- 238000003747 Grignard reaction Methods 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 150000002680 magnesium Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- ZQGAXHXHVKVERC-UHFFFAOYSA-N 1-benzofuran-2-carbonitrile Chemical compound C1=CC=C2OC(C#N)=CC2=C1 ZQGAXHXHVKVERC-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- CLMSHAWYULIVFQ-UHFFFAOYSA-N 3-bromo-3h-2-benzofuran-1-one Chemical compound C1=CC=C2C(Br)OC(=O)C2=C1 CLMSHAWYULIVFQ-UHFFFAOYSA-N 0.000 description 1
- PGIJLXGFXADEIQ-UHFFFAOYSA-N 4-(4-fluorobenzoyl)benzonitrile Chemical compound C1=CC(F)=CC=C1C(=O)C1=CC=C(C#N)C=C1 PGIJLXGFXADEIQ-UHFFFAOYSA-N 0.000 description 1
- LBLDZAMVULDYOX-UHFFFAOYSA-N 4-[bis(4-fluorophenyl)-hydroxymethyl]-2-(hydroxymethyl)benzonitrile Chemical compound OCC1=C(C#N)C=CC(=C1)C(O)(C1=CC=C(C=C1)F)C1=CC=C(C=C1)F LBLDZAMVULDYOX-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- GCJYYUGXODRJJT-UHFFFAOYSA-N [4-bromo-2-(hydroxymethyl)phenyl]-(4-fluorophenyl)methanol Chemical compound OCC1=CC(Br)=CC=C1C(O)C1=CC=C(F)C=C1 GCJYYUGXODRJJT-UHFFFAOYSA-N 0.000 description 1
- DSXGDABDEZITPU-UHFFFAOYSA-N [4-bromo-2-(hydroxymethyl)phenyl]-(4-fluorophenyl)methanone Chemical compound OCC1=CC(Br)=CC=C1C(=O)C1=CC=C(F)C=C1 DSXGDABDEZITPU-UHFFFAOYSA-N 0.000 description 1
- DVVKRMISXLKYIF-UHFFFAOYSA-N [Br].FC1=CC=C(C=C1)[Mg] Chemical compound [Br].FC1=CC=C(C=C1)[Mg] DVVKRMISXLKYIF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000006332 fluoro benzoyl group Chemical group 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- NGPAITITALWALP-UHFFFAOYSA-M magnesium;n,n-dimethylpropan-1-amine;chloride Chemical compound [Mg+2].[Cl-].CN(C)CC[CH2-] NGPAITITALWALP-UHFFFAOYSA-M 0.000 description 1
- 235000019988 mead Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000479A ITMI20030479A1 (it) | 2003-03-13 | 2003-03-13 | Procedimento per la preparazione di un ciano-isobenzofurano. |
| ITMI2003A000479 | 2003-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20050108376A true KR20050108376A (ko) | 2005-11-16 |
Family
ID=32983208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020057016274A Withdrawn KR20050108376A (ko) | 2003-03-13 | 2004-03-09 | 시아노-이소벤조퓨란의 제조방법 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7411077B2 (https=) |
| EP (1) | EP1601662A1 (https=) |
| JP (1) | JP2006520351A (https=) |
| KR (1) | KR20050108376A (https=) |
| CN (1) | CN1761658A (https=) |
| AU (1) | AU2004220410A1 (https=) |
| BR (1) | BRPI0408732A (https=) |
| CA (1) | CA2514458A1 (https=) |
| HR (1) | HRP20050893A2 (https=) |
| IT (1) | ITMI20030479A1 (https=) |
| MX (1) | MXPA05008411A (https=) |
| WO (1) | WO2004080988A1 (https=) |
| ZA (1) | ZA200505592B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE428421T1 (de) | 2004-09-17 | 2009-05-15 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften |
| WO2008059514A2 (en) * | 2006-07-31 | 2008-05-22 | Cadila Healthcare Limited | Process for preparing escitalopram |
| US20170290333A1 (en) | 2014-12-30 | 2017-10-12 | Dow Agrosciences Llc | Picolinamide compounds with fungicidal activity |
| CA3030551C (en) | 2016-07-07 | 2025-05-06 | Corteva Agriscience Llc | PROCESSES FOR PREPARATION OF 4-ALCOXY-3-(ACYL OR ALKYL)OXYPICOLINAMIDES |
| CN108929245A (zh) * | 2017-05-25 | 2018-12-04 | 万全万特制药江苏有限公司 | 艾司西酞普兰工艺杂质的制备方法 |
| CN108947869A (zh) * | 2017-05-25 | 2018-12-07 | 万全万特制药江苏有限公司 | 一种艾司西酞普兰工艺杂质的制备方法 |
| CN120097946A (zh) * | 2025-02-28 | 2025-06-06 | 浙江工业大学 | 一种应用脱水膜强化5-氰二醇盐酸盐醚化制西酞普兰溴酸盐的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| ES2148120T3 (es) * | 1997-07-08 | 2002-01-16 | Lundbeck & Co As H | Metodo para la preparacion de citalopram. |
| UA62985C2 (en) * | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
| EA002770B1 (ru) * | 1997-11-11 | 2002-08-29 | Х.Лундбекк А/С | Способ получения циталопрама |
| US6310222B1 (en) * | 1999-11-01 | 2001-10-30 | Sumika Fine Chemicals Co., Ltd. | Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| JP3641420B2 (ja) * | 1999-11-01 | 2005-04-20 | 住友化学株式会社 | ５−フタランカルボニトリル化合物の製造方法、その中間体およびその製造方法 |
| US6433196B1 (en) | 2000-02-17 | 2002-08-13 | Sumika Fine Chemicals Co., Ltd. | Production method of citalopram, intermediate therefor and production method of the intermediate |
| JP3735026B2 (ja) * | 2000-02-17 | 2006-01-11 | 住友化学株式会社 | シタロプラムの製造方法、およびその中間体とその製造方法 |
-
2003
- 2003-03-13 IT IT000479A patent/ITMI20030479A1/it unknown
-
2004
- 2004-03-09 JP JP2006504646A patent/JP2006520351A/ja active Pending
- 2004-03-09 BR BRPI0408732-1A patent/BRPI0408732A/pt not_active IP Right Cessation
- 2004-03-09 ZA ZA200505592A patent/ZA200505592B/en unknown
- 2004-03-09 US US10/549,062 patent/US7411077B2/en not_active Expired - Fee Related
- 2004-03-09 HR HR20050893A patent/HRP20050893A2/hr not_active Application Discontinuation
- 2004-03-09 WO PCT/EP2004/002522 patent/WO2004080988A1/en not_active Ceased
- 2004-03-09 MX MXPA05008411A patent/MXPA05008411A/es unknown
- 2004-03-09 CA CA002514458A patent/CA2514458A1/en not_active Abandoned
- 2004-03-09 EP EP04718658A patent/EP1601662A1/en not_active Withdrawn
- 2004-03-09 CN CNA2004800068530A patent/CN1761658A/zh active Pending
- 2004-03-09 AU AU2004220410A patent/AU2004220410A1/en not_active Abandoned
- 2004-03-09 KR KR1020057016274A patent/KR20050108376A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN1761658A (zh) | 2006-04-19 |
| ZA200505592B (en) | 2006-09-27 |
| HRP20050893A2 (en) | 2005-12-31 |
| ITMI20030479A1 (it) | 2004-09-14 |
| US20060183925A1 (en) | 2006-08-17 |
| AU2004220410A1 (en) | 2004-09-23 |
| JP2006520351A (ja) | 2006-09-07 |
| BRPI0408732A (pt) | 2006-03-07 |
| WO2004080988A1 (en) | 2004-09-23 |
| EP1601662A1 (en) | 2005-12-07 |
| CA2514458A1 (en) | 2004-09-23 |
| US7411077B2 (en) | 2008-08-12 |
| MXPA05008411A (es) | 2005-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3447267B2 (ja) | シタロプラムの製造方法 | |
| JP3798982B2 (ja) | 純粋なシタロプラムの製造方法 | |
| FR2957079A1 (fr) | Procede de synthese de derives de cetobenzofurane | |
| EP2595976A1 (fr) | Procede de preparation de derives d'amino-benzoyl-benzofurane | |
| JP2008516005A (ja) | レトロゾールの改良された調製方法 | |
| KR20050108376A (ko) | 시아노-이소벤조퓨란의 제조방법 | |
| JP4331618B2 (ja) | シタロプラムの製造方法 | |
| JP2009515945A (ja) | 塩酸ドネペジルの調製に有用な中間体およびその新規な多形の改善された合成および調製 | |
| JP2015526507A (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| US20140371457A1 (en) | Process for production of quinuclidine compounds | |
| EP1988086B1 (en) | Process for resolving citalopram via its (S)-enriched citalopram tartrate compound. | |
| US20040254385A1 (en) | Process for the preparation of citalopram hydrobromide | |
| JPH053858B2 (https=) | ||
| EA011763B1 (ru) | Способы получения венлафаксина и формы i венлафаксина гидрохлорида | |
| WO2001085688A1 (en) | TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS | |
| JP4397990B2 (ja) | ３−アルキルフラバノノール誘導体の精製法 | |
| JPS62155268A (ja) | ナイザチジンの合成法 | |
| JP3047582B2 (ja) | トレオ−４−アルコキシ−５−（アリールヒドロキシメチル）−２（５ｈ）−フラノンの製造方法 | |
| JP4480802B2 (ja) | 臭素化剤 | |
| JP2008510797A (ja) | ４−フルオロ−α−［２−メチル−１−オキソプロピル］γ−オキソ−Ｎ−β−ジフェニルベンゼンブタンアミドの製造方法 | |
| EP1678122A1 (en) | Improved process for the manufacture of citalopram hydrobromide | |
| JPH10175913A (ja) | 光学活性２−フェノキシプロピオン酸の製造方法 | |
| JPH0550517B2 (https=) | ||
| JPH07103115B2 (ja) | ２−（１０，１１−ジヒドロ−１０−オキソジベンゾ〔ｂ，ｆ〕チエピン−２−イル）プロピオン酸の結晶化方法 | |
| CS232331B1 (cs) | Způsob přípravy tricyklických antidepresiv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20050901 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |